Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
9/18/24 GSK (GSK) Shingrix for Chickenpox and Shingles - Vaccines and Treatments Subscribers Only Subscribers Only Subscribers Only
9/18/24 GSK (GSK) Arexvy for Respiratory Syncytial Virus (RSV) Prevention Subscribers Only Subscribers Only Subscribers Only
9/16/24 Betta Pharmaceuticals (300558) BPI-16350 for HR+/HER2- Breast Cancer Subscribers Only Subscribers Only Subscribers Only
9/16/24 Bayer (BAYN) Nubeqa for Prostate Cancer Subscribers Only Subscribers Only Subscribers Only
9/16/24 AstraZeneca (AZN) Imfinzi for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
01/01/25 - 03/31/24 Subscribers Only Subscribers Only Trial Announcement - Initiation
01/01/25 - 04/30/24 Subscribers Only Subscribers Only Progress Update - Product Launch
07/31/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion
09/12/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/19/24 Subscribers Only Subscribers Only Trial Data - Updated Results